Nature Communications (Feb 2022)
Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice
Abstract
Here, the authors show that expression of kindlin-2 is increased in patients with nonalcoholic fatty liver disease (NAFLD). In mouse models, specific deletion of kindlin-2 in liver ameliorates, while its overexpression exacerbates, NAFLD by modulating Foxo1 in hepatocytes.